Contraceptive Market Research Report by Drugs (Contraceptive Injectable, Emergency Contraceptive Pills, and Oral Contraceptives), by Gender (Female Contraceptive Devices and Male Contraceptive Devices), by Distribution, by State (California, Florida, and

Contraceptive Market Research Report by Drugs (Contraceptive Injectable, Emergency Contraceptive Pills, and Oral Contraceptives), by Gender (Female Contraceptive Devices and Male Contraceptive Devices), by Distribution, by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19

The United States Contraceptive Market size was estimated at USD 8,459.11 million in 2020 and expected to reach USD 10,598.41 million in 2021, at a CAGR 22.21% to reach USD 28,192.20 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drugs, the market was studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches.

Based on Gender, the market was studied across Female Contraceptive Devices and Male Contraceptive Devices.

Based on Distribution, the market was studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Contraceptive Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Contraceptive Market, including Agile Therapeutics, Allergan Plc, Ani Pharmaceuticals Inc., Bayer Corporation, Church & Dwight Co., Inc., CooperSurgical, Inc., Fuji Latex Co. Ltd, Gilead Sciences Inc., Johnson & Johnson, Mayer Laboratories, Inc., Merck & Co. Inc., Pfizer Inc, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., and Veru Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Contraceptive Market?
4. What is the competitive strategic window for opportunities in the United States Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the United States Contraceptive Market?
6. What is the market share of the leading vendors in the United States Contraceptive Market?
7. What modes and strategic moves are considered suitable for entering the United States Contraceptive Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Contraceptive Market, by Drugs
6.1. Introduction
6.2. Contraceptive Injectable
6.3. Emergency Contraceptive Pills
6.4. Oral Contraceptives
6.5. Transdermal Patches
7. Contraceptive Market, by Gender
7.1. Introduction
7.2. Female Contraceptive Devices
7.3. Male Contraceptive Devices
8. Contraceptive Market, by Distribution
8.1. Introduction
8.2. Clinics
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform
9. California Contraceptive Market
10. Florida Contraceptive Market
11. Illinois Contraceptive Market
12. New York Contraceptive Market
13. Ohio Contraceptive Market
14. Pennsylvania Contraceptive Market
15. Texas Contraceptive Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Agile Therapeutics
17.2. Allergan Plc
17.3. Ani Pharmaceuticals Inc.
17.4. Bayer Corporation
17.5. Church & Dwight Co., Inc.
17.6. CooperSurgical, Inc.
17.7. Fuji Latex Co. Ltd
17.8. Gilead Sciences Inc.
17.9. Johnson & Johnson
17.10. Mayer Laboratories, Inc.
17.11. Merck & Co. Inc.
17.12. Pfizer Inc
17.13. Reckitt Benckiser Group Plc
17.14. Teva Pharmaceuticals Industries Ltd.
17.15. Veru Inc.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CONTRACEPTIVE MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CONTRACEPTIVE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES CONTRACEPTIVE MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2026
FIGURE 7. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTABLE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTABLE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVE PILLS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVE PILLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL PATCHES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2020 VS 2026 (%)
FIGURE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2026
FIGURE 18. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE DEVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE DEVICES, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE DEVICES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
FIGURE 23. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2026
FIGURE 25. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES CONTRACEPTIVE MARKET: FPNV POSITIONING MATRIX
FIGURE 34. UNITED STATES CONTRACEPTIVE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 35. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CONTRACEPTIVE MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES CONTRACEPTIVE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES CONTRACEPTIVE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTABLE, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVE PILLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL PATCHES, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE DEVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE DEVICES, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES CONTRACEPTIVE MARKET: SCORES
TABLE 18. UNITED STATES CONTRACEPTIVE MARKET: BUSINESS STRATEGY
TABLE 19. UNITED STATES CONTRACEPTIVE MARKET: PRODUCT SATISFACTION
TABLE 20. UNITED STATES CONTRACEPTIVE MARKET: RANKING
TABLE 21. UNITED STATES CONTRACEPTIVE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 22. UNITED STATES CONTRACEPTIVE MARKET: MERGER & ACQUISITION
TABLE 23. UNITED STATES CONTRACEPTIVE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 24. UNITED STATES CONTRACEPTIVE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 25. UNITED STATES CONTRACEPTIVE MARKET: INVESTMENT & FUNDING
TABLE 26. UNITED STATES CONTRACEPTIVE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 27. UNITED STATES CONTRACEPTIVE MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook